BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20522337)

  • 1. S-1 induces meibomian gland dysfunction.
    Matsumoto Y; Dogru M; Sato EA; Ibrahim OM; Tatematsu Y; Ogawa Y; Tsubota K
    Ophthalmology; 2010 Jun; 117(6):1275.e4-7. PubMed ID: 20522337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].
    Kase S
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():490-3. PubMed ID: 25831809
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of corneal epithelial lesion and keratoconjunctival pigmentation due to anticancer drug S-1.
    Kobashi H; Kamiya K; Shimizu K
    Jpn J Ophthalmol; 2011 Mar; 55(2):163-5. PubMed ID: 21400063
    [No Abstract]   [Full Text] [Related]  

  • 4. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain.
    Viso E; Gude F; Rodríguez-Ares MT
    Cornea; 2011 Jan; 30(1):1-6. PubMed ID: 20847672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three cases of corneal disorders associated with an oral anticancer drug S-1].
    Ito S; Tanaka A
    Nippon Ganka Gakkai Zasshi; 2006 Nov; 110(11):919-23. PubMed ID: 17134039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel thermodynamic treatment for meibomian gland dysfunction.
    Friedland BR; Fleming CP; Blackie CA; Korb DR
    Curr Eye Res; 2011 Feb; 36(2):79-87. PubMed ID: 21281063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meibomian gland dysfunction--review].
    Nowińska A; Wylegała E; Tarnawska D; Janiszewska D; Dobrowolskia D
    Klin Oczna; 2012; 114(2):147-52. PubMed ID: 23346806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation.
    Gupta S; Silliman CG; Trump DL
    Prostate Cancer Prostatic Dis; 2007; 10(4):396-7. PubMed ID: 17404582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects analyses in consideration of renal function for S-1-administered patients].
    Iwai M; Kimura M; Yoshimura T; Yasuda T
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):973-6. PubMed ID: 21677489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.
    Pinna A; Piccinini P; Carta F
    Cornea; 2007 Apr; 26(3):260-4. PubMed ID: 17413949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Isotretinoin on Meibomian Glands.
    Moy A; McNamara NA; Lin MC
    Optom Vis Sci; 2015 Sep; 92(9):925-30. PubMed ID: 26154692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility of S-1/CDDP therapy for outpatients with advanced gastric cancer].
    Rino Y; Murakami H; Yukawa N; Wada N; Oshima T; Matsuura H; Sugano N; Arai H; Masuda M; Imada T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1829-31. PubMed ID: 19920383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye.
    Joffre C; Souchier M; Grégoire S; Viau S; Bretillon L; Acar N; Bron AM; Creuzot-Garcher C
    Br J Ophthalmol; 2008 Jan; 92(1):116-9. PubMed ID: 18156378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for ocular complications caused by anticancer drug S-1.
    Yamada R; Sotozono C; Nakamura T; Nishida A; Nakanishi S; Hirabatake M; Tsuji A; Kurimoto Y
    Jpn J Ophthalmol; 2016 Mar; 60(2):63-71. PubMed ID: 26842341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity by an oral anti-neoplatic agent, S-1.
    Ohara G; Satoh H; Hizawa N
    Intern Med; 2008; 47(3):187; author reply 189. PubMed ID: 18239333
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease.
    Albietz JM; Lenton LM
    Cornea; 2006 Oct; 25(9):1012-9. PubMed ID: 17133045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of in vivo laser scanning confocal microscopy for evaluation of ocular surface diseases: lessons learned from pterygium, meibomian gland disease, and chemical burns.
    Wang Y; Le Q; Xu J
    Cornea; 2012 Aug; 31(8):968. PubMed ID: 22511027
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location.
    Korb DR; Blackie CA
    Cornea; 2008 Dec; 27(10):1142-7. PubMed ID: 19034129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.